Unicycive Therapeutics Free Cash Flow (FCF) History (UNCY)
Unicycive Therapeutics reported −$31.3M in free cash flow for fiscal 2025, a decrease of $2.7M from the previous fiscal year.
View full Unicycive Therapeutics company overviewUnicycive Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$31.3M | −$2.7M | — | — |
| 2024 | 2024-12-31 | −$28.6M | −$10.4M | — | — |
| 2023 | 2023-12-31 | −$18.3M | −$2.6M | — | −2710.37% |
| 2022 | 2022-12-31 | −$15.7M | −$9.9M | — | −1645.95% |
| 2021 | 2021-12-31 | −$5.8M | — | — | — |
Unicycive Therapeutics quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$7.6M | $821,000 | — | — |
| Q1 2026 | 2026-03-31 | −$6.2M | $2.7M | — | — |
| Q4 2025 | 2025-12-31 | −$8.0M | −$1.5M | — | — |
| Q3 2025 | 2025-09-30 | −$6.0M | $3.3M | — | — |
| Q2 2025 | 2025-06-30 | −$8.4M | −$2.1M | — | — |
| Q1 2025 | 2025-03-31 | −$8.9M | −$2.5M | — | — |
| Q4 2024 | 2024-12-31 | −$6.6M | −$2.1M | — | — |
| Q3 2024 | 2024-09-30 | −$9.3M | −$3.2M | — | — |
| Q2 2024 | 2024-06-30 | −$6.3M | −$2.8M | — | — |
| Q1 2024 | 2024-03-31 | −$6.5M | −$3.4M | — | — |
| Q3 2023 | 2023-09-30 | −$4.4M | −$1.5M | — | — |
| Q4 2022 | 2022-12-31 | −$6.1M | — | — | — |
| Q3 2022 | 2022-09-30 | −$3.6M | — | — | −374.66% |
| Q2 2022 | 2022-06-30 | −$3.0M | — | — | — |
| Q1 2022 | 2022-03-31 | −$3.0M | — | — | — |
Unicycive Therapeutics free cash flow growth trends
Unicycive Therapeutics's latest reported quarter, Q2 2026, generated −$7.6M in free cash flow, an increase of $821,000 year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Unicycive Therapeutics filings at SEC.gov ↗